4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-057966
Chief Financial Officer sold 11,095 shares at $3.57 ($39,609)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. Chief Financial Officer | 2022-11-16 | Sale | −11,095 | $3.57 | $39,609 | 323,764 | D: show line 1 in the form |
| Open-market sales · 11,095 sh · avg $3.57 · $39,609 | |||||||
Loading xslF345X03/doc4.xml…